Victory Capital Management Inc. Sells 37,386 Shares of Huron Consulting Group Inc. (NASDAQ:HURN)

Victory Capital Management Inc. lowered its stake in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 82.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,692 shares of the business services provider's stock after selling 37,386 shares during the period. Victory Capital Management Inc.'s holdings in Huron Consulting Group were worth $956,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Allspring Global Investments Holdings LLC boosted its holdings in shares of Huron Consulting Group by 61.3% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,972 shares of the business services provider's stock valued at $1,488,000 after purchasing an additional 4,550 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Huron Consulting Group by 29.1% during the 3rd quarter. Wellington Management Group LLP now owns 538,290 shares of the business services provider's stock valued at $58,512,000 after purchasing an additional 121,371 shares during the last quarter. Franklin Resources Inc. increased its position in Huron Consulting Group by 20.5% during the 3rd quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider's stock worth $42,306,000 after purchasing an additional 67,239 shares in the last quarter. Atom Investors LP bought a new position in Huron Consulting Group in the 3rd quarter valued at approximately $1,159,000. Finally, Natixis Advisors LLC boosted its position in Huron Consulting Group by 32.7% in the third quarter. Natixis Advisors LLC now owns 18,571 shares of the business services provider's stock valued at $2,019,000 after buying an additional 4,576 shares in the last quarter. Institutional investors own 93.90% of the company's stock.

Remove Ads

Insider Buying and Selling

In other news, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $125.15, for a total value of $130,406.30. Following the completion of the sale, the director now owns 24,672 shares in the company, valued at $3,087,700.80. The trade was a 4.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director James H. Roth sold 2,000 shares of the business's stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $123.69, for a total transaction of $247,380.00. Following the transaction, the director now owns 50,534 shares in the company, valued at $6,250,550.46. The trade was a 3.81 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 72,140 shares of company stock valued at $10,492,517 over the last quarter. Insiders own 2.02% of the company's stock.

Huron Consulting Group Trading Up 1.4 %

Shares of HURN stock traded up $2.00 on Monday, hitting $142.87. The company had a trading volume of 315,657 shares, compared to its average volume of 124,061. Huron Consulting Group Inc. has a twelve month low of $84.26 and a twelve month high of $153.85. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market cap of $2.53 billion, a P/E ratio of 31.06 and a beta of 0.53. The stock's 50-day moving average is $134.50 and its two-hundred day moving average is $122.52.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last released its earnings results on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, beating analysts' consensus estimates of $1.52 by $0.38. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $399.31 million during the quarter, compared to the consensus estimate of $380.62 million. On average, equities research analysts anticipate that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Wedbush started coverage on Huron Consulting Group in a research note on Monday, February 3rd. They issued an "outperform" rating for the company. Barrington Research increased their target price on Huron Consulting Group from $142.00 to $167.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Benchmark upped their price objective on Huron Consulting Group from $140.00 to $165.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Truist Financial raised their price objective on shares of Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a report on Tuesday, March 4th. Finally, William Blair restated an "outperform" rating on shares of Huron Consulting Group in a research report on Monday, March 10th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $155.50.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.